Clinical trial · Observational
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
NCT01063998CI-TRIAL-00012607terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Preliminary data did not show expected outcomes.
Summary
Brief summary (as posted)
The ultimate goal of this project is to develop a simple non-invasive method to screen patients for potential kidney tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Urine Marker | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Group 1
- description
- Patients demonstrate normal serum creatinine and no radiological evidence of a renal tumor.
- interventionNames
- Other: Urine Marker
- label
- p 2
- description
- Patients diagnosed with renal cancer and normal creatinine.
- interventionNames
- Other: Urine Marker
Primary outcomes (1)
- measure
- To test the sensitivity and specificity of KIM-1 urine excretion in a group of patients with kidney cancer.
- timeFrame
- 1 month
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients demonstrate normal serum creatinine and no radiological evidence of a renal tumor. OR * Patients diagnosed with renal cancer and normal creatinine. Exclusion Criteria: * None.
References
Publications (0)
Data not yet available
No reference posted for this study.